fda safety communication semaglutide vision loss naion 2025 and Eye Health: A Look at Risk The obesity drug semaglutide (Wegovy)

The FDA-approved prescribing information for Ozempic carries a boxed warning about thyroid C-cell tumors observed in rodents, making personal and family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 an absolute contraindication [3]

Bitter orange extract: P-Synephrine

Our clients range from: Busy moms in their 30s-40s seeking natural weight loss and energy boosts Athletes and first responders looking to recover faster and stay strong through demanding schedules High performers and executives who want better focus, sleep, and brain clarity Men and women in their 50s+ wanting to age powerfully, not passively Peptides are safe, effective, and fully tailored to your goalswhen prescribed and monitored by a licensed medical provider

A history of pregnancy or breastfeeding , medullary thyroid carcinoma, or multiple endocrine neoplasia syndrome type 2 will prevent approval

The results showed that the combined group, which did 150 minutes of cardio a week, lost 6.1% in abdominal fat